Thomas Robert Gildea, MD, FCCP, FACP was appointed to Cleveland Clinic in 2003 to Department of Pulmonary Allergy and Critical Care Medicine & Transplant Center and is the Section Head of Bronchology in the Respiratory Institute, leading a team of dedicated Interventional Pulmonologists.  He has been board-certified in internal medicine, pulmonary disease and critical care medicine.

He has advanced training in interventional and advanced diagnostic bronchoscopy, which was part of his fellowship training at Cleveland Clinic. His clinical interests span the realm of advanced lung diseases, including lung volume reduction, lung transplantation, pulmonary arterial hypertension and is most focused on advanced diagnostic and therapeutic bronchoscopy.

Dr. Gildea was the first physician in North America to perform electromagnetic navigation bronchoscopy. He was given an Innovator Award at Cleveland Clinic in 2006 with his team proposing a novel device for a bronchoscopy needle-delivered fiducial lung implant. He has been named one of the Best Doctors in America since 2007. He also received a physician development award by the AlphaOne Foundation to study lung function changes after lung transplantation. In 2010 he completed a Master's degree at Case Western Reserve in Clinical Research. He was granted an NIH-NCAI grant for the initial work to form VisionAir Solutions around his idea for patient-specific airway stenting.

An invited lecturer at national and international medical meetings, Dr. Gildea is a recognized expert in the field of interventional pulmonary medicine. In addition to leading the VisionAir Solutions SAB, Dr. Gildea serves on advisory boards for several medical device companies and on several boards and committees of national specialty societies.

‍